Literature DB >> 93703

Shape change of blood platelets brought about by myelin basic protein and other basic polypeptides.

A Laubscher, A Pletscher, C G Honegger, J G Richards.   

Abstract

Basic proteins and polypeptides (BPP) such as myelin basic protein (MBP), polyornithine (M.W. 40,000), polylysine and protamine, which are known to cause neuronal depolarization in the central nervous system, induced a shape change reaction in blood platelets of various species, including man. This reaction was not accompanied by platelet aggregation or marked alterations of 5-hydroxytryptamine release. Cyclic nucleotide levels were also unchanged. The shape change induced by polyornithine was inhibited by heparin but not by antagonists of 5HT, catecholamines or gamma-aminobutryic acid, substances which are known to have no effect on the MBP-induced neuronal depolarization. Other basic substances, e.g. low molecular weight polyornithine (M.W. 4,000), cytochrome c, spermine and spermidine, did not induce either platelet shape change or (as shown before) neuronal depolarization. It is concluded, that 1) the shape change reaction of platelets seems to be a sensitive and simple means of detecting those BPP which induce functional changes in mammalian cells and 2) the use of platelets as models for neurons can be extended to include the action of BPP on the plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93703     DOI: 10.1007/bf00499878

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

Review 1.  Cyclic nucleotides in platelet function.

Authors:  R J Haslam; M M Davidson; J E Fox; J A Lynham
Journal:  Thromb Haemost       Date:  1978-10-31       Impact factor: 5.249

2.  Effect of serotonin on cyclic nucleotides of human platelets.

Authors:  K C Agarwal; M Steiner
Journal:  Biochem Biophys Res Commun       Date:  1976-04-19       Impact factor: 3.575

3.  Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs.

Authors:  A Laubscher; A Pletscher
Journal:  Life Sci       Date:  1979-05-14       Impact factor: 5.037

4.  Effects of cationic polypeptides on thrombasthenic and afibrinogenemic blood platelets.

Authors:  J G White
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

5.  Platelet surface charge and aggregation. Effects of polyelectrolytes.

Authors:  K A Gröttum
Journal:  Thromb Diath Haemorrh       Date:  1969-06-15

6.  Blood platelets isolated by polysaccharide gradients: reaction to 5-hydroxytryptamine.

Authors:  M Graf; A Laubscher; J G Richards; A Pletscher
Journal:  J Lab Clin Med       Date:  1979-02

7.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

8.  Myelin basic protein depolarizes neuronal membranes.

Authors:  B H Gähwiler; C G Honegger
Journal:  Neurosci Lett       Date:  1979-03       Impact factor: 3.046

9.  Shape change of blood platelets induced by myelin basic protein.

Authors:  A Laubscher; A Pletscher; C G Honegger; J G Richards; V Colombo
Journal:  Experientia       Date:  1979-08-15

10.  The effect of myelin basic protein (MBP) on the bioelectric activity of spinal cord and cerebellar neurones.

Authors:  C G Honegger; B H Gähwiler; H Isler
Journal:  Neurosci Lett       Date:  1977-05       Impact factor: 3.046

View more
  3 in total

1.  Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.

Authors:  F Gudat; A Laubscher; U Otten; A Pletscher
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

Review 2.  Myelin basic protein and multiple sclerosis.

Authors:  J N Whitaker
Journal:  Ital J Neurol Sci       Date:  1983-06

3.  Myelin basic protein induces neuron-specific toxicity by directly damaging the neuronal plasma membrane.

Authors:  Jie Zhang; Xin Sun; Sixin Zheng; Xiao Liu; Jinghua Jin; Yi Ren; Jianhong Luo
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.